US Patent Issued to Epimeron USA on June 23 for "Recombinant olivetolic acid cyclase polypeptides engineered for enhanced biosynthesis of cannabinoids" (Canadian, American Inventors)

ALEXANDRIA, Va., July 15 -- United States Patent no. 12,662,666, issued on June 23, was assigned to Epimeron USA Inc. (Sunnyvale, Calif.).

"Recombinant olivetolic acid cyclase polypeptides engineered for enhanced biosynthesis of cannabinoids" was invented by Trish Choudhary (Belmont, Calif.), Xueyang Feng (Fremont, Calif.), Thanh Nguyen (Fremont, Calif.) and Matthew Workentine (Calgary, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to recombinant polypeptides that have olivetolic acid cyclase activity, nucleic acids encoding these recombinant polypeptides, recombinant host cells that produce these recombinant polypeptides, and compositions comprising the recombinant pol...